|Company name||Express Scripts, Inc.|
|Live stock price||[stckqut]ESRX[/stckqut]|
|P/E compared to competitors||Fair|
|Confident Investor Rating||Good|
|Target stock price (TWCA growth scenario)||$42.15|
|Target stock price (averages with growth)||$61.19|
|Target stock price (averages with no growth)||$54.8|
|Target stock price (manual assumptions)||$45.03|
The following company description is from Google Finance: http://www.google.com/finance?q=esrx
Express Scripts, Inc. is a pharmacy benefit management (PBM) operating in North America, offering a range of services to its clients, which include health maintenance organizations (HMOs), health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and Government health programs. The Company has organized its operations into two business segments based on products and services offered: PBM and Emerging Markets (EM). The Company’s revenues are generated from the delivery of prescription drugs through its contracted network of retail pharmacies, home delivery and specialty pharmacy services and EM services. In October 2010, the Company completed the spinoff of its Rx Outreach business unit. In November 2010, the Company announced the formation of Express Scripts Specialty Benefit Services, a specialty benefits company.
Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.